Clinical Trials Directory

Trials / Sponsors / Oyster Point Pharma, Inc.

Oyster Point Pharma, Inc.

Industry · 11 registered clinical trials.

StatusTrialPhaseStarted
TerminatedA Study Evaluating the Safety of the Nasal Pump
Dry Eye, Kerato Conjunctivitis Sicca
Phase 42024-02-21
CompletedPhase 4 Study Evaluating the Safety of the Nasal Guide With Tyrvaya
Dry Eye, Keratoconjunctivitis Sicca
Phase 42023-06-14
CompletedPhase 2 Clinical Trial to Evaluate OC-01 Nasal Spray in Subjects With Neurotrophic Keratopathy
Neurotrophic Keratopathy
Phase 22021-06-17
CompletedEvaluating Relative Bioavailability of OC-01 (Varenicline) Nasal Spray as Compared to Orally Administered Vare
Healthy Subjects
Phase 12019-08-26
CompletedEvaluation of the Efficacy and Safety of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease
Dry Eye Disease (DED)
Phase 32019-07-23
CompletedClinical Trial to Evaluate the Chronic Efficacy of OC-01 Nasal Spray on Signs of Dry Eye Disease (The MYSTIC S
Dry Eye Disease
Phase 22019-02-18
CompletedEfficacy of OC-01 Nasal Spray on Goblet Cell and Meibomian Gland Stimulation
Dry Eye Disease
Phase 22018-09-25
CompletedEvaluation of the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease
Dry Eye Disease
Phase 22018-08-15
CompletedEvaluation of the Long Term Follow up of the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Di
Long Term Follow up Dry Eye Disease
Phase 2 / Phase 32018-08-15
CompletedEvaluation of the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (the RAINIER Study)
Dry Eye Disease
Phase 22018-08-14
CompletedClinical Trial to Evaluate the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The PEA
Dry Eye Disease
Phase 22018-02-27